Sevoflurane Liquid
Product Images NDC 10019-655

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Sevoflurane (NDC 10019-655). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Sevoflurane Structural Formula (Image 01)

Sevoflurane Structural Formula (Image 01)
The given text is not available.*
FDA Label Image

Figure 1 (Fresh Gas Flow Rate versus Compound A Levels in a Circle Absorber System)

Figure 1 (Fresh Gas Flow Rate versus Compound A Levels in a Circle Absorber System)
FDA Label Image

Figure 2 (Carbon Dioxide Flow Versus Compound A and Maximum Temperature)

Figure 2 (Carbon Dioxide Flow Versus Compound A and Maximum Temperature)
FDA Label Image

Figure 2a (ppm hr versus MAC hr at flow Rate of 1 L/min)

Figure 2a (ppm hr versus MAC hr at flow Rate of 1 L/min)
FDA Label Image

Figure 3. Ratio Of Concentration Of Anesthetic In Alveolar Gas To Inspired Gas (Image 05)

Figure 3. Ratio Of Concentration Of Anesthetic In Alveolar Gas To Inspired Gas (Image 05)
FDA Label Image

Figure 4 (Concentration of Anesthetic in Alveolar Gas Following Termination of Anesthesia)

Figure 4 (Concentration of Anesthetic in Alveolar Gas Following Termination of Anesthesia)
Not available.*
FDA Label Image

Figure 5 (Serum Inorganic Fluoride Concentration for Sevoflurane and Other Volatile Anesthetics)

Figure 5 (Serum Inorganic Fluoride Concentration for Sevoflurane and Other Volatile Anesthetics)
FDA Label Image

Figure 6 Fluoride Ion Concentration Following Administration Of Sevoflurane (Image 08)

Figure 6 Fluoride Ion Concentration Following Administration Of Sevoflurane (Image 08)
FDA Label Image

Figure 7 (Heart Rate)

Figure 7 (Heart Rate)
FDA Label Image

Figure 8 (Mean Arterial Pressure)

Figure 8 (Mean Arterial Pressure)
FDA Label Image

Figure 9 (Systemic Vascular Resistance)

Figure 9 (Systemic Vascular Resistance)
FDA Label Image

Figure 10 (Cardiac Index)

Figure 10 (Cardiac Index)
FDA Label Image

Sevoflurane, Usp Representative Container Label (Image 13)

Sevoflurane, Usp Representative Container Label (Image 13)
This is a description for Sevoflurane, USP, which is an inhalation anesthetic used for anesthesia. The package includes a 200mL container with usual dosage instructions provided in the package insert. The product is manufactured by Baxter Healthcare Corporation and should not be used if the tamper-evident seal is broken. For product inquiries, contact 1-800 ANA DRUG. The address of the manufacturer is Deerfeld, IL 60015, USA.*
FDA Label Image

Sevoflurane, Usp Representative Carton Label (Image 14)

Sevoflurane, Usp Representative Carton Label (Image 14)
Sevoflurane,USP is a type of medication that is available in six bottles and is used for inhalation. It should be stored at a controlled room temperature of 15°C to 30°C. The medication is produced by Baxter Healthcare Corporation in Deerfield, USA. However, the remaining text such as "LlueERELRRRLIARLL", "Exp 85 9999 Lot Q1230123", "TR BB", "O A", and "o0ee 475-630-02" are not clear and appear to have errors, making them not-available for interpretation.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.